Riskpilot← Back to searchSign inGet full accessONEMED TWO ApS
APSActiveCVR 35648615Kappa 3Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2014— employees
Revenue 2025
DKK -42K
+407% vs 2024
EBITDA margin
100.0%
-407% vs 2024
Equity ratio
3.4%
Financial strength
Net profit 2025
DKK -32K
-555% vs 2024
| Revenue | DKK -42K | +407% |
| EBITDA | DKK -42K | -407% |
| Net profit | DKK -32K | -555% |
| Total assets | DKK 65K | -3% |
| Equity | DKK 2K | -49% |
| Employees | — | — |
Legal name
ONEMED TWO ApS
CVR number
35648615
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15. januar 2014
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at producere og drive handel med hospitals- og sygeplejeartikler samt al virksomhed, som efter direktionens skøn har forbindelse hermed
Address
Kappa 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -5 | -5 | -5 | -6 | -7 | -7 | -8 | -8 | -8 | -8 | -8 | -42 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -5 | -5 | -5 | -6 | -7 | -7 | -8 | -8 | -8 | -8 | -8 | -42 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -5 | -5 | -5 | -6 | -7 | -7 | -8 | -8 | -8 | -8 | -8 | -42 |
| Net financials | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 2 | 2 | 1 |
| Profit before tax | -4 | -3 | -3 | -5 | -6 | -6 | -7 | -7 | -8 | -7 | -6 | -41 |
| Tax | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | -2 | -1 | -1 | -9 |
| Net profit | -3 | -2 | -3 | -4 | -5 | -5 | -6 | -6 | -6 | -5 | -5 | -32 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 52 | 54 | 56 | 58 | 60 | 59 | 60 | 63 | 64 | 64 | 67 | 65 |
| Equity | 47 | 45 | 45 | 41 | 36 | 32 | 26 | 20 | 14 | 9 | 4 | 2 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 9 | 11 | 17 | 23 | 27 | 34 | 43 | 50 | 55 | 63 | 63 |
| Total debt | 5 | 9 | 11 | 17 | 23 | 27 | 34 | 43 | 50 | 55 | 63 | 63 |
EBITDA margin
-4181200.0%
This company
15.8%
Market median
-26463391% vs market
20142025
Equity ratio
3.4%
This company
38.2%
Market median
-91% vs market
20142025
Return on equity
-1462.5%
This company
18.4%
Market median
-8048% vs market
20142025
Net profit margin
-3207300.0%
This company
8.1%
Market median
-39596396% vs market
20142025
Asset turnover
-0.64×
This company
1.12×
Market median
-157% vs market
20142025
Debt / equity
28.81×
This company
0.62×
Market median
-4547% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-15 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KR Management | Management | 2026 | — | — |
MN Management | Management | 2015 | — | — |
JK Management | Management | 2014 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ONEMED A/S | Company | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ONEMED A/S
ONEMED TWO ApS Board members of ONEMED TWO ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kirstine Rylev Holm | Management | 0 companies |
| Morten Nielsen | Management | 0 companies |
| Jan Knoph | Management | 0 companies |